BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Adocia 

115 avenue Lacassagne

Lyon    69003  France
Phone: +33-(0)4-72-610-610 Fax: +33-(0)4-72-363-967


SEARCH JOBS




Industry
Biotechnology

Segment
Biotechnology





 Company News
Adocia Reports Positive Preliminary Results From Dose Response Clinical Study Of Ultra-fast Acting BioChaperone® Lispro U100 In Patients With Type 1 Diabetes 9/9/2014 9:22:33 AM
Adocia Launches Phase III Clinical Study In India Of Treatment For Diabetic Foot Ulcer 8/25/2014 10:15:49 AM
Adocia Reports Operational And Financial Results For The First Half Of 2014 7/24/2014 12:21:53 PM
Adocia Announces Approval To Start A Phase IIa Clinical Study Of Hinsbet®, Its Fast-Acting Human Insulin, In Type 1 Diabetes 7/9/2014 11:02:40 AM
Adocia Reports Positive Results From Phase 2a Clinical Study Of Ultra-Fast Acting Biochaperone® Lispro 4/9/2014 2:16:54 PM
Adocia Announces Financial Results For 2013 3/26/2014 11:22:43 AM
Adocia Confirms Positive Clinical Results For Its Biochaperone® Combo, A Combination Of Long-Acting Insulin Glargine And Fast-Acting Insulin Lispro 3/20/2014 11:41:00 AM
Adocia Announces Preliminary Positive Clinical Results For Its Combination Of Long-Acting Insulin Glargine And Fast-Acting Insulin Analog Lispro, Biochaperone® Combo 2/27/2014 11:11:28 AM
Adocia: Annual Revenue Of EUR 5.6 Million In 2013 2/18/2014 1:20:22 PM
Adocia Strengthens Its Diabetic Foot Ulcer Patent Portfolio 1/13/2014 10:04:45 AM
123